Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
historical diagnosis of type 2 diabetes mellitus for at least 6 months and less than 10 years before screening
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hemoglobin A1c measurement | Absence Washout Antidiabetics Oral | Washout Antidiabetics Oral
Item
hba1c <10% at screening for subjects who do not require washout of existing oad or <9% at screening for subjects who do require washout from existing oad
boolean
C0474680 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C1710661 (UMLS CUI [2,2])
C0935929 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
C1710661 (UMLS CUI [3,1])
C0935929 (UMLS CUI [3,2])
C1527415 (UMLS CUI [3,3])
Body mass index
Item
body mass index in range 28 kg/m2 to40 kg/m2
boolean
C1305855 (UMLS CUI [1])
History of pancreatitis | Gall Bladder Disease Symptomatic | Pancreatitis Symptomatic
Item
history of pancreatitis or current ongoing symptomatic biliary disease or pancreatitis
boolean
C3887021 (UMLS CUI [1])
C0016977 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0030305 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
Gastrointestinal Surgical Procedure
Item
history of significant gastrointestinal surgery,
boolean
C0524722 (UMLS CUI [1])
Cardiovascular Disease
Item
history of significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Epilepsy
Item
history of a seizure disorder
boolean
C0014544 (UMLS CUI [1])
Hypertensive disease | Hypotension
Item
documented hypertension or hypotension
boolean
C0020538 (UMLS CUI [1])
C0020649 (UMLS CUI [2])
Antidiabetics Oral | Exception Metformin
Item
use of oral antidiabetic agents, except for metformin, within 14 days before investigational product administration.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Liver disease | Liver function tests abnormal finding
Item
current hepatic disease or abnormal liver function tests
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
Hepatitis B test positive | Hepatitis C test positive | HIV-1 test positive | HIV-2 test positive
Item
positive test result for hepatitis b, hepatitis c, or human immunodeficiency virus infection 1 or 2
boolean
C1608966 (UMLS CUI [1])
C1609517 (UMLS CUI [2])
C1328593 (UMLS CUI [3])
C1168371 (UMLS CUI [4])
Alcohol consumption Regular | Alcoholic drinks per week | Gender
Item
history of regular alcohol consumption (exceeding 7 drinks/week for women or 14 drinks/week for men)
boolean
C0001948 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0001967 (UMLS CUI [2,1])
C0332174 (UMLS CUI [2,2])
C0079399 (UMLS CUI [3])
Pregnancy | Breast Feeding | Postpartum Period
Item
female subject is pregnant (confirmed by laboratory testing), lactating, or less than 6 weeks postpartum
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0086839 (UMLS CUI [3])
Hypersensitivity GLP-1 Analogue | Hypersensitivity Albiglutide Excipient | Hypersensitivity Saccharomyces cerevisiae | Insulin allergy
Item
known allergy to any glp-1 analog or excipients of albiglutide, baker's yeast, or insulin
boolean
C0020517 (UMLS CUI [1,1])
C3273809 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2607479 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0036025 (UMLS CUI [3,2])
C0571622 (UMLS CUI [4])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes,
boolean
C0011854 (UMLS CUI [1])
Exposure to GLP-1 Receptor Agonist | Exposure to Albiglutide
Item
prior exposure to glp-1 agents, including albiglutide
boolean
C0332157 (UMLS CUI [1,1])
C2917359 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C2607479 (UMLS CUI [2,2])
Blood Donation Amount Timespan
Item
blood donation over 500 ml within 8 weeks before screening
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0872291 (UMLS CUI [1,3])